Polypoidal Choroidal Vasculopathy (PCV)
A patient diagnosed with neovascular AMD in the left eye was referred to retina clinic at Bascom Palmer Eye Institute because of poor answer to monthly Ranibizumab and Bevacizumab intra vitreal injections. VA was 20/200 in the left eye. OCT showed intra retinal (IRF), sub-retinal fluid (SRF) and pigment epithelial detachment (PED). ICG showed 2 polyps temporal to optic nerve. She was diagnosed with polypoidal choroidal vasculopathy (PCV). Right eye was unremarkable at the time of presentation. Treatment with biweekly Ranibizumab and Bevacizumab started and SRF, IRF and PED resolved. Treatment extended later with Aflibercept, and patient was followed with no more injections for 5 years. 10 years after presentation, the right eye showed 2 polyps on the SS-OCTA imaging and became symptomatic later. Treatment started with Aflibercept and IRF and SRF resolved. Treatment was stopped for a year because of no exudation on the imaging. Patient presented after a year with massive vitreous and sub-retinal hemorrhage in the left eye and VA dropped from 20/20 to 20/400. Treatment with Aflibercept started.
Presentation Date: 06/17/2021
Issue Date: 07/02/2021
Please log in or click on ENROLL ME to access this course.
